Market Insights Health Hospitals Inpatient Care

Treatment of Musculoskeletal Diseases - Portugal

Portugal

In Portugal, the Treatment of Musculoskeletal Diseases market is anticipated to achieve a revenue of US$131.70m by the year 2024.
It is estimated that this revenue will experience an annual growth rate (CAGR 2024-2029) of 3.02%.
As a result, the market volume is projected to reach US$152.80m by 2029.
When compared globally, United States is expected to generate the highest revenue in this market, reaching an impressive US$60,790.00m in 2024.
Portugal is experiencing a surge in the use of alternative therapies for the treatment of musculoskeletal diseases.

Key regions: Europe, Canada, United States, Germany, India

Market

Region

Region comparison

Currency

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on revenue received by hospitals from public or private sources, allocated to the country where the money is spent, including VAT if applicable.

Modeling approach / Market size:

Market sizes are determined by a bottom-up approach, based on a specific rationale for each market market. Next, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, public health spend, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.